Kevin Dooley

1.4k total citations · 1 hit paper
20 papers, 801 citations indexed

About

Kevin Dooley is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Kevin Dooley has authored 20 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Biomaterials. Recurrent topics in Kevin Dooley's work include Extracellular vesicles in disease (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Kevin Dooley is often cited by papers focused on Extracellular vesicles in disease (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Kevin Dooley collaborates with scholars based in United States, France and Vietnam. Kevin Dooley's co-authors include Scott Banta, Basak E. Uygun, Julie Devallière, Martin L. Yarmush, Su Chul Jang, Kyriakos D. Economides, Tong Zi, Alan C. West, Donald M. Cropek and Chang Ling Sia and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Kevin Dooley

20 papers receiving 780 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

2022 190 citations Sushrut Kamerkar, Charan Leng et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Dooley United States	14	468	173	155	139	112	20	801
Chuanxu Yang Denmark	23	676 1.4×	389 2.2×	354 2.3×	112 0.8×	78 0.7×	43	1.5k
Min Nie China	16	295 0.6×	100 0.6×	182 1.2×	101 0.7×	89 0.8×	32	740
Nuno A. Fonseca Portugal	16	540 1.2×	322 1.9×	295 1.9×	107 0.8×	99 0.9×	28	1.0k
Jagannath Mondal South Korea	10	301 0.6×	225 1.3×	225 1.5×	93 0.7×	53 0.5×	17	657
Gholamreza Tavoosidana Iran	13	428 0.9×	115 0.7×	130 0.8×	138 1.0×	63 0.6×	43	758
Xinyu Qiu China	10	510 1.1×	103 0.6×	112 0.7×	146 1.1×	111 1.0×	27	808
Ziba Veisi Malekshahi Iran	12	293 0.6×	162 0.9×	149 1.0×	103 0.7×	54 0.5×	28	612
Hirohito Ayame Japan	12	425 0.9×	132 0.8×	98 0.6×	100 0.7×	51 0.5×	17	746
Xiao-Qi Wang United States	15	698 1.5×	117 0.7×	85 0.5×	149 1.1×	181 1.6×	18	1.1k
Wei‐Yun Lai Taiwan	18	500 1.1×	208 1.2×	287 1.9×	119 0.9×	121 1.1×	29	1.1k

Countries citing papers authored by Kevin Dooley

Since Specialization

Citations

This map shows the geographic impact of Kevin Dooley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Dooley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Dooley more than expected).

Fields of papers citing papers by Kevin Dooley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Dooley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Dooley. The network helps show where Kevin Dooley may publish in the future.

Co-authorship network of co-authors of Kevin Dooley

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Dooley. A scholar is included among the top collaborators of Kevin Dooley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Dooley. Kevin Dooley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Shil, Karl Schmidt, Mohammed Farhoud, et al.. (2022). In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration. Nuclear Medicine and Biology. 112-113. 20–30. 39 indexed citations

Kamerkar, Sushrut, Charan Leng, Olga Burenkova, et al.. (2022). Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity. Science Advances. 8(7). eabj7002–eabj7002. 190 indexed citations breakdown →

Kirwin, Katherine, Su Chul Jang, Kevin Dooley, et al.. (2021). 572 Combination therapy of exoSTING, exoIL-12 activates systemic anti-tumor immunity. SHILAP Revista de lepidopterología. A601–A601. 3 indexed citations

Lewis, Nuruddeen D., Chang Ling Sia, Katherine Kirwin, et al.. (2020). Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12. Molecular Cancer Therapeutics. 20(3). 523–534. 79 indexed citations

Lewis, Nuruddeen D., Chang Ling Sia, Katherine Kirwin, et al.. (2020). 709 Exosome surface display of IL-12 results in tumor-retained pharmacology with superior potency and limited systemic exposure. SHILAP Revista de lepidopterología. A425.2–A426. 3 indexed citations

Kauke, Monique J., Nikki L. Ross, Dalia Burzyn, et al.. (2020). 703 Engineered exosomes with altered cellular tropism achieve targeted STING agonist delivery and single-agent tumor control in vivo. SHILAP Revista de lepidopterología. A422.2–A423. 1 indexed citations

Jang, Su Chul, Raymond J. Moniz, Chang Ling Sia, et al.. (2019). Abstract 944: exoSTING: An engineered exosome therapeutic that selectively delivers STING agonist to the tumor resident antigen-presenting cells resulting in improved tumor antigen-specific adaptive immune response. Cancer Research. 79(13_Supplement). 944–944. 10 indexed citations

Dooley, Kevin, Ke Xu, Sonya Haupt, et al.. (2019). Abstract 2150: engEx: A novel exosome engineering platform enabling targeted transfer of pharmacological molecules. 2150–2150. 2 indexed citations

Devallière, Julie, Yibin Chen, Kevin Dooley, Martin L. Yarmush, & Basak E. Uygun. (2018). Improving functional re-endothelialization of acellular liver scaffold using REDV cell-binding domain. Acta Biomaterialia. 78. 151–164. 63 indexed citations

10.

Lin, Xia, Khiem Nguyen, Yaovi Holade, et al.. (2017). Improving the Performance of Methanol Biofuel Cells Utilizing an Enzyme Cascade Bioanode with DNA-Bridged Substrate Channeling. ACS Energy Letters. 2(6). 1435–1438. 30 indexed citations

11.

Devallière, Julie, et al.. (2017). Co-delivery of a growth factor and a tissue-protective molecule using elastin biopolymers accelerates wound healing in diabetic mice. Biomaterials. 141. 149–160. 88 indexed citations

12.

Bulutoglu, Beyza, Kevin Dooley, Géza R. Szilvay, Mark Blenner, & Scott Banta. (2017). Catch and Release: Engineered Allosterically Regulated β-Roll Peptides Enable On/Off Biomolecular Recognition. ACS Synthetic Biology. 6(9). 1732–1741. 14 indexed citations

13.

Dooley, Kevin, Julie Devallière, Basak E. Uygun, & Martin L. Yarmush. (2016). Functionalized Biopolymer Particles Enhance Performance of a Tissue-Protective Peptide under Proteolytic and Thermal Stress. Biomacromolecules. 17(6). 2073–2079. 9 indexed citations

14.

Jang, Woo‐Sik, et al.. (2015). Enzymatically triggered rupture of polymersomes. Soft Matter. 12(4). 1014–1020. 21 indexed citations

15.

Dooley, Kevin, Beyza Bulutoglu, & Scott Banta. (2014). Doubling the Cross-Linking Interface of a Rationally Designed Beta Roll Peptide for Calcium-Dependent Proteinaceous Hydrogel Formation. Biomacromolecules. 15(10). 3617–3624. 24 indexed citations

16.

Banta, Scott, et al.. (2013). Replacing Antibodies: Engineering New Binding Proteins. Annual Review of Biomedical Engineering. 15(1). 93–113. 71 indexed citations

17.

Dooley, Kevin, et al.. (2013). A Designed, Phase Changing RTX-Based Peptide for Efficient Bioseparations. BioTechniques. 54(4). 197–206. 13 indexed citations

18.

Dooley, Kevin, Yang Hee Kim, Hoang D. Lu, Raymond S. Tu, & Scott Banta. (2012). Engineering of an Environmentally Responsive Beta Roll Peptide for Use As a Calcium-Dependent Cross-Linking Domain for Peptide Hydrogel Formation. Biomacromolecules. 13(6). 1758–1764. 47 indexed citations

19.

Wu, Jun, Jong Pil Park, Kevin Dooley, et al.. (2011). Rapid Development of New Protein Biosensors Utilizing Peptides Obtained via Phage Display. PLoS ONE. 6(10). e24948–e24948. 51 indexed citations

20.

Şahin, Aslı, Kevin Dooley, Donald M. Cropek, Alan C. West, & Scott Banta. (2011). A dual enzyme electrochemical assay for the detection of organophosphorus compounds using organophosphorus hydrolase and horseradish peroxidase. Sensors and Actuators B Chemical. 158(1). 353–360. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact